Journal of Endocrinological Investigation

, Volume 41, Issue 5, pp 531–538 | Cite as

Evaluation of the Italian cytological subclassification of thyroid indeterminate nodules into TIR-3A and TIR-3B: a retrospective study of 290 cases with histological correlation from a single institution

  • E. Rullo
  • G. Minelli
  • D. Bosco
  • F. Nardi
  • V. Ascoli
Original Article

Abstract

Purpose

The Italian consensus to classify thyroid cytology has provided a standardized reporting scheme, including the subdivision of indeterminate for malignancy TIR-3 category into TIR-3A (low-risk) and TIR-3B (high-risk). We aimed to present our experience on this subclassification by evaluating risks of malignancy and the validity in sorting nodules with dissimilar risks. Another aim was to compare our performance against the Bethesda system.

Methods

Fine-needle aspirates of 290 TIR-3 that underwent thyroid surgery at our hospital (2008–2013) were reviewed and divided into TIR-3A or TIR-3B, and AUS/FLUS or FN/SFN. Cytological diagnoses were then correlated to histology. Results were evaluated using univariate analysis.

Results

The subclassification into TIR-3A and TIR-3B differentiated hyperplastic nodules (p = 0.000) but not adenomas (p = 0.090). Rates of malignancy were significantly different between TIR-3A (10.2%) and TIR-3B (43.8%); TIR-3B malignancies were often papillary carcinomas (83%). TIR-3A/TIR-3B accounted for high sensitivity (84.5%; CI 79.7–88.4%), accuracy (64.1%; CI 58.6–69.6%) and NPV (89.8%; CI 85.6–93.0%) as opposed to modest specificity (55.8%; CI 49.9–61.6%) and PPV (43.8%; CI 38.1–49.8%). The rate of malignancy in AUS-FLUS was higher than in TIR-3A (p = 0.007), whereas it was not different between FN/SFN and TIR-3B (p = 0.337). Sensitivity of the Bethesda system was significantly lower respect to the Italian system.

Conclusions

The study supports the Italian consensus showing a different risk of malignancy for TIR-3A as compared to TIR-3B. TIR-3A/TIR-3B subclassification is valid to sort out benign nodules (high NPV) and malignancies (high sensitivity) but not adenomas (modest specificity, low PPV). In our experience, sensitivity is the main difference between Italian and Bethesda systems.

Keywords

Thyroid cancer Thyroid nodule Indeterminate fine-needle aspiration cytology Classification 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

For this type of study, archival material was used so that formal consent is not required. The study was designated as exempt by the ethics committee due to its retrospective nature; moreover, no protected health information was used.

Informed consent

Consent to submit the article has been received explicitly from all co-authors, as well as from the responsible authorities at the institute/organization where the work has been carried out.

Funding

No funding sources were received/used for this study.

References

  1. 1.
    Cibas ES, Ali SZ, NCI Thyroid FNA State of the Science Conference (2009) The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132:658–665. doi: 10.1309/AJCPPHLWMI3JV4LA CrossRefPubMedGoogle Scholar
  2. 2.
    Cross P, Chandra A, Giles T et al (2016) Guidance on the reporting of thyroid cytology specimens. R. Coll. Pathol, LondonGoogle Scholar
  3. 3.
    Fadda G, Basolo F, Bondi A et al (2010) Cytological classification of thyroid nodules. Proposal of the SIAPEC-IAP Italian Consensus Working Group. Pathologica 102:405–408PubMedGoogle Scholar
  4. 4.
    Nardi F, Basolo F, Crescenzi A et al (2014) Italian consensus for the classification and reporting of thyroid cytology. J Endocrinol Invest 37:593–599. doi: 10.1007/s40618-014-0062-0 CrossRefPubMedGoogle Scholar
  5. 5.
    Baloch ZW, LiVolsi VA, Asa SL et al (2008) Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the national cancer institute thyroid fine-needle aspiration state of the science conference. Diagn Cytopathol 36:425–437. doi: 10.1002/dc.20830 CrossRefPubMedGoogle Scholar
  6. 6.
    Tysome JR, Chandra A, Chang F et al (2009) Improving prediction of malignancy of cytologically indeterminate thyroid nodules. Br J Surg 96:1400–1405. doi: 10.1002/bjs.6734 CrossRefPubMedGoogle Scholar
  7. 7.
    Deandrea M, Ragazzoni F, Motta M et al (2010) Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation. Thyroid 20:1077–1083. doi: 10.1089/thy.2010.0015 CrossRefPubMedGoogle Scholar
  8. 8.
    Bongiovanni M, Spitale A, Faquin WC et al (2012) The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol 56:333–339. doi: 10.1159/000339959 CrossRefPubMedGoogle Scholar
  9. 9.
    Pagni F, Prada M, Goffredo P et al (2014) “Indeterminate for malignancy” (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact. Cytopathology 25:170–176. doi: 10.1111/cyt.12085 CrossRefPubMedGoogle Scholar
  10. 10.
    Kholová I, Ludvíková M (2014) Thyroid atypia of undetermined significance or follicular lesion of undetermined significance: an indispensable Bethesda 2010 diagnostic category or waste garbage? Acta Cytol 58:319–329. doi: 10.1159/000366498 CrossRefPubMedGoogle Scholar
  11. 11.
    Ustun B, Chhieng D, Van Dyke A et al (2014) Risk stratification in follicular neoplasm: a cytological assessment using the modified Bethesda classification. Cancer Cytopathol 122:536–545. doi: 10.1002/cncy.21425 CrossRefPubMedGoogle Scholar
  12. 12.
    Fatman L, Michelow P (2015) Thyroid cytopathology with an emphasis on the “atypical cells of uncertain significance” category: a 3-year audit with cytohistologic correlation. Acta Cytol 59:17–25. doi: 10.1159/000369331 CrossRefPubMedGoogle Scholar
  13. 13.
    Ho AS, Sarti EE, Jain KS et al (2014) Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid 24:832–839. doi: 10.1089/thy.2013.0317 CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Brophy C, Mehanna R, Mccarthy J et al (2015) Clinical thyroidology/original paper outcome of subclassification of indeterminate (Thy-3) thyroid cytology into Thy-3a and Thy-3f. Eur Thyroid J 4:246–251. doi: 10.1159/000441221 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Kim SJ, Roh J, Baek JH et al (2017) Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology. Cytopathology 28:65–73. doi: 10.1111/cyt.12352 CrossRefPubMedGoogle Scholar
  16. 16.
    Krauss EA, Mahon M, Fede JM, Zhang L (2016) Application of the Bethesda classification for thyroid fine-needle aspiration institutional experience and meta-analysis. Arch Pathol Lab Med 140:1121–1131. doi: 10.5858/arpa.2015-0154-SA CrossRefPubMedGoogle Scholar
  17. 17.
    Grani G, Lamartina L, Ascoli V et al (2016) Ultrasonography scoring systems can rule out malignancy in cytologically indeterminate thyroid nodules. Endocrine 57:1–6. doi: 10.1007/s12020-016-1148-6 Google Scholar
  18. 18.
    Nikiforov YE, Seethala RR, Tallini G et al (2016) Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma. JAMA Oncol 2:1023. doi: 10.1001/jamaoncol.2016.0386 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Baloch ZW, Seethala RR, Faquin WC et al (2016) Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a changing paradigm in thyroid surgical pathology and implications for thyroid cytopathology. Cancer Cytopathol 124:616–620. doi: 10.1002/cncy.21744 CrossRefPubMedGoogle Scholar
  20. 20.
    Maletta F, Massa F, Torregrossa L et al (2016) Cytological features of “noninvasive follicular thyroid neoplasm with papillary-like nuclear features” and their correlation with tumor histology. Hum Pathol 54:134–142. doi: 10.1016/j.humpath.2016.03.014 CrossRefPubMedGoogle Scholar
  21. 21.
    Schreiner AM, Yang GCH (2012) Adenomatoid nodules are the main cause for discrepant histology in 234 thyroid fine-needle aspirates reported as follicular neoplasm. Diagn Cytopathol 40:375–379. doi: 10.1002/dc.21499 CrossRefPubMedGoogle Scholar
  22. 22.
    Alexander EK, Kennedy GC, Baloch ZW et al (2012) Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med 367:705–715. doi: 10.1056/NEJMoa1203208 CrossRefPubMedGoogle Scholar
  23. 23.
    Batista FA, Ward LS, Marcello MA et al (2016) Gene expression of thyroid-specific transcription factors may help diagnose thyroid lesions but are not determinants of tumor progression. J Endocrinol Invest 39:423–429. doi: 10.1007/s40618-015-0386-4 CrossRefPubMedGoogle Scholar
  24. 24.
    Pagni F, Mainini V, Garancini M et al (2015) Proteomics for the diagnosis of thyroid lesions: preliminary report. Cytopathology 26:318–324. doi: 10.1111/cyt.12166 CrossRefPubMedGoogle Scholar
  25. 25.
    Nishigami K, Liu Z, Taniguchi E et al (2012) Cytological features of well-differentiated tumors of uncertain malignant potential: indeterminate cytology and WDT-UMP. Endocr J 59:483–487. doi: 10.1507/endocrj.EJ11-0261 CrossRefPubMedGoogle Scholar
  26. 26.
    Elliott DD, Pitman MB, Bloom L, Faquin WC (2006) Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: a cytomorphologic study of 139 cases with statistical analysis. Cancer 108:102–109. doi: 10.1002/cncr.21716 CrossRefPubMedGoogle Scholar
  27. 27.
    Sung S, Saqi A, Margolskee E, Crapanzano J (2017) Cytomorphologic features distinguishing Bethesda category IV thyroid lesions from parathyroid. Cytojournal 14:10. doi: 10.4103/1742-6413.205313 CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Autelitano F, Spagnoli LG, Santeusanio G et al (1990) Occult carcinoma of the thyroid gland: an epidemiological study of autopsy material. Ann Ital Chir 61:141–146PubMedGoogle Scholar
  29. 29.
    Mahajan S, Srinivasan R, Rajwanshi A et al (2017) Risk of malignancy and risk of neoplasia in the Bethesda indeterminate categories: study on 4,532 thyroid fine-needle aspirations from a single institution in India. Acta Cytol. doi: 10.1159/000470825 PubMedGoogle Scholar
  30. 30.
    Straccia P, Rossi ED, Bizzarro T et al (2015) A meta-analytic review of the Bethesda system for reporting thyroid cytopathology: has the rate of malignancy in indeterminate lesions been underestimated? Cancer Cytopathol 123:713–722. doi: 10.1002/cncy.21605 CrossRefPubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2017

Authors and Affiliations

  1. 1.Dipartimento di Scienze Radiologiche, Oncologiche e Anatomo-PatologicheUniversità SapienzaRomeItaly
  2. 2.Unità di StatisticaIstituto Superiore di SanitàRomeItaly

Personalised recommendations